Varex Imaging Corporation (NASDAQ: VREX) Stock Competitors & Peer Comparison

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ABT trades at $111.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ABT's P/E ratio is 21.36. In terms of profitability, VREX's ROE is +0.05%, compared to ABT's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ABT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BSX-PA trades at $122.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VREX's ROE is +0.05%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSX-PA's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SYK has a market cap of 130.8B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SYK trades at $341.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SYK's P/E ratio is 25.47. In terms of profitability, VREX's ROE is +0.05%, compared to SYK's ROE of +0.16%. Regarding short-term risk, VREX is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SYK's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, MDT has a market cap of 116B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while MDT trades at $90.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas MDT's P/E ratio is 16.38. In terms of profitability, VREX's ROE is +0.05%, compared to MDT's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check MDT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BSX has a market cap of 76.9B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BSX trades at $51.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BSX's P/E ratio is 16.68. In terms of profitability, VREX's ROE is +0.05%, compared to BSX's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, EW has a market cap of 53.3B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while EW trades at $92.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas EW's P/E ratio is 34.29. In terms of profitability, VREX's ROE is +0.05%, compared to EW's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for VREX.Check EW's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while DXCM trades at $91.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas DXCM's P/E ratio is 39.26. In terms of profitability, VREX's ROE is +0.05%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, VREX is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check DXCM's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, RMD has a market cap of 32.9B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while RMD trades at $226.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas RMD's P/E ratio is 21.06. In terms of profitability, VREX's ROE is +0.05%, compared to RMD's ROE of +0.24%. Regarding short-term risk, VREX is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check RMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PHG has a market cap of 26.8B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PHG trades at $27.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PHG's P/E ratio is 15.64. In terms of profitability, VREX's ROE is +0.05%, compared to PHG's ROE of +0.10%. Regarding short-term risk, VREX is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PHG's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ZBH trades at $99.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ZBH's P/E ratio is 11.74. In terms of profitability, VREX's ROE is +0.05%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, VREX is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ZBH's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ABMD trades at $381.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VREX's ROE is +0.05%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VREX is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for VREX.Check ABMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PEN trades at $326.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PEN's P/E ratio is 85.36. In terms of profitability, VREX's ROE is +0.05%, compared to PEN's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PEN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SNN has a market cap of 12.7B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SNN trades at $30.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SNN's P/E ratio is 14.17. In terms of profitability, VREX's ROE is +0.05%, compared to SNN's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SNN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ALGN has a market cap of 12.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ALGN trades at $176.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ALGN's P/E ratio is 16.06. In terms of profitability, VREX's ROE is +0.05%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, VREX is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ALGN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SWAV trades at $334.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VREX's ROE is +0.05%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, VREX is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SWAV's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while GMED trades at $85.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas GMED's P/E ratio is 19.36. In terms of profitability, VREX's ROE is +0.05%, compared to GMED's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for VREX.Check GMED's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while GKOS trades at $189.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas GKOS's P/E ratio is -220.30. In terms of profitability, VREX's ROE is +0.05%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, VREX is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check GKOS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PODD trades at $146.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PODD's P/E ratio is 24.95. In terms of profitability, VREX's ROE is +0.05%, compared to PODD's ROE of +0.27%. Regarding short-term risk, VREX is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PODD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BIO trades at $361.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BIO's P/E ratio is 38.93. In terms of profitability, VREX's ROE is +0.05%, compared to BIO's ROE of +0.03%. Regarding short-term risk, VREX is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BIO's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BIO-B trades at $348.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, VREX's ROE is +0.05%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, VREX is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for VREX.Check BIO-B's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while MASI trades at $179.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas MASI's P/E ratio is 44.43. In terms of profitability, VREX's ROE is +0.05%, compared to MASI's ROE of +0.09%. Regarding short-term risk, VREX is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for VREX.Check MASI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BRKR trades at $57.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BRKR's P/E ratio is 29.11. In terms of profitability, VREX's ROE is +0.05%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, VREX is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BRKR's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while NARI trades at $79.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas NARI's P/E ratio is -59.24. In terms of profitability, VREX's ROE is +0.05%, compared to NARI's ROE of -0.00%. Regarding short-term risk, VREX is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for VREX.Check NARI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while LIVN trades at $82.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas LIVN's P/E ratio is 19.19. In terms of profitability, VREX's ROE is +0.05%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, VREX is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LIVN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ITGR trades at $125.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ITGR's P/E ratio is 19.69. In terms of profitability, VREX's ROE is +0.05%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, VREX is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ITGR's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while HAE trades at $90.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas HAE's P/E ratio is 18.06. In terms of profitability, VREX's ROE is +0.05%, compared to HAE's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for VREX.Check HAE's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while IRTC trades at $123.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas IRTC's P/E ratio is -192.44. In terms of profitability, VREX's ROE is +0.05%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, VREX is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IRTC's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AXNX trades at $70.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VREX's ROE is +0.05%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VREX is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for VREX.Check AXNX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while TMDX trades at $89.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas TMDX's P/E ratio is 45.50. In terms of profitability, VREX's ROE is +0.05%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, VREX is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TMDX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AXGN trades at $48.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AXGN's P/E ratio is 126.45. In terms of profitability, VREX's ROE is +0.05%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, VREX is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AXGN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while UFPT trades at $319.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas UFPT's P/E ratio is 32.67. In terms of profitability, VREX's ROE is +0.05%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, VREX is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check UFPT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BFLY trades at $8.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BFLY's P/E ratio is -36.79. In terms of profitability, VREX's ROE is +0.05%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, VREX is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BFLY's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ESTA trades at $75.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ESTA's P/E ratio is -59.99. In terms of profitability, VREX's ROE is +0.05%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, VREX is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ESTA's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while NUVA trades at $39.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VREX's ROE is +0.05%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VREX is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NUVA's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while NVCR trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas NVCR's P/E ratio is -11.36. In terms of profitability, VREX's ROE is +0.05%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, VREX is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NVCR's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while INSP trades at $58.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas INSP's P/E ratio is 25.62. In terms of profitability, VREX's ROE is +0.05%, compared to INSP's ROE of +0.18%. Regarding short-term risk, VREX is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INSP's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while TNDM trades at $23.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas TNDM's P/E ratio is -21.03. In terms of profitability, VREX's ROE is +0.05%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, VREX is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TNDM's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ATEC trades at $9.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ATEC's P/E ratio is -162.50. In terms of profitability, VREX's ROE is +0.05%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, VREX is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ATEC's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CNMD trades at $49.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CNMD's P/E ratio is 10.94. In terms of profitability, VREX's ROE is +0.05%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, VREX is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CNMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ENOV trades at $25.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ENOV's P/E ratio is 7.36. In terms of profitability, VREX's ROE is +0.05%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, VREX is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ENOV's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while IART trades at $18.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas IART's P/E ratio is 7.73. In terms of profitability, VREX's ROE is +0.05%, compared to IART's ROE of -0.01%. Regarding short-term risk, VREX is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IART's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AORT trades at $28.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AORT's P/E ratio is 47.38. In terms of profitability, VREX's ROE is +0.05%, compared to AORT's ROE of -0.01%. Regarding short-term risk, VREX is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AORT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while HSKA trades at $119.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VREX's ROE is +0.05%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VREX is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for VREX.Check HSKA's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PRCT trades at $21.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PRCT's P/E ratio is -11.31. In terms of profitability, VREX's ROE is +0.05%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, VREX is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PRCT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AVNS trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AVNS's P/E ratio is 27.77. In terms of profitability, VREX's ROE is +0.05%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, VREX is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for VREX.Check AVNS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while LMRI trades at $12.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas LMRI's P/E ratio is -22.82. In terms of profitability, VREX's ROE is +0.05%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, VREX is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LMRI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SILK trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SILK's P/E ratio is -18.96. In terms of profitability, VREX's ROE is +0.05%, compared to SILK's ROE of -0.35%. Regarding short-term risk, VREX is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SILK's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while IRMD trades at $87.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas IRMD's P/E ratio is 43.80. In terms of profitability, VREX's ROE is +0.05%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, VREX is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check IRMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while FNA trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas FNA's P/E ratio is -19.83. In terms of profitability, VREX's ROE is +0.05%, compared to FNA's ROE of -0.35%. Regarding short-term risk, VREX is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for VREX.Check FNA's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BVS has a market cap of 941M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BVS trades at $13.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BVS's P/E ratio is 18.28. In terms of profitability, VREX's ROE is +0.05%, compared to BVS's ROE of +0.28%. Regarding short-term risk, VREX is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BVS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CBLL has a market cap of 882.2M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CBLL trades at $23.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CBLL's P/E ratio is -14.26. In terms of profitability, VREX's ROE is +0.05%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, VREX is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CBLL's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, INMD has a market cap of 873.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while INMD trades at $15.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas INMD's P/E ratio is 10.56. In terms of profitability, VREX's ROE is +0.05%, compared to INMD's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AVR has a market cap of 868.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AVR trades at $8.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AVR's P/E ratio is -4.00. In terms of profitability, VREX's ROE is +0.05%, compared to AVR's ROE of -0.78%. Regarding short-term risk, VREX is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AVR's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CSII trades at $20.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CSII's P/E ratio is -20.83. In terms of profitability, VREX's ROE is +0.05%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VREX is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for VREX.Check CSII's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SIBN has a market cap of 840.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SIBN trades at $18.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SIBN's P/E ratio is -55.74. In terms of profitability, VREX's ROE is +0.05%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, VREX is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SIBN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BBNX has a market cap of 813.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BBNX trades at $18.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BBNX's P/E ratio is -11.97. In terms of profitability, VREX's ROE is +0.05%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, VREX is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BBNX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while AHCO trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas AHCO's P/E ratio is 11.63. In terms of profitability, VREX's ROE is +0.05%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, VREX is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check AHCO's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SSII has a market cap of 766.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SSII trades at $3.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SSII's P/E ratio is -74.70. In terms of profitability, VREX's ROE is +0.05%, compared to SSII's ROE of -0.27%. Regarding short-term risk, VREX is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SSII's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BWAY has a market cap of 646M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BWAY trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BWAY's P/E ratio is 41.84. In terms of profitability, VREX's ROE is +0.05%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, VREX is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BWAY's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, KIDS has a market cap of 642.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while KIDS trades at $25.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas KIDS's P/E ratio is -21.19. In terms of profitability, VREX's ROE is +0.05%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, VREX is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check KIDS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CTKB trades at $4.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CTKB's P/E ratio is -25.91. In terms of profitability, VREX's ROE is +0.05%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, VREX is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CTKB's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SRDX trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SRDX's P/E ratio is -34.66. In terms of profitability, VREX's ROE is +0.05%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, VREX is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SRDX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while DCTH trades at $17.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, VREX's ROE is +0.05%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, VREX is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for VREX.Check DCTH's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while APEN trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas APEN's P/E ratio is -9.43. In terms of profitability, VREX's ROE is +0.05%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VREX is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check APEN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CERS has a market cap of 572.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CERS trades at $2.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CERS's P/E ratio is -56.69. In terms of profitability, VREX's ROE is +0.05%, compared to CERS's ROE of -0.10%. Regarding short-term risk, VREX is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CERS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ZIMV trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, VREX's ROE is +0.05%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, VREX is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for VREX.Check ZIMV's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, TCMD has a market cap of 534.8M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while TCMD trades at $23.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas TCMD's P/E ratio is 26.94. In terms of profitability, VREX's ROE is +0.05%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, VREX is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TCMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, NPCE has a market cap of 494.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while NPCE trades at $14.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas NPCE's P/E ratio is -22.32. In terms of profitability, VREX's ROE is +0.05%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, VREX is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NPCE's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CLPT has a market cap of 462.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CLPT trades at $15.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CLPT's P/E ratio is -13.07. In terms of profitability, VREX's ROE is +0.05%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, VREX is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CLPT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SGHT has a market cap of 452.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SGHT trades at $8.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SGHT's P/E ratio is -14.86. In terms of profitability, VREX's ROE is +0.05%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, VREX is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SGHT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, OFIX has a market cap of 411.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while OFIX trades at $10.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas OFIX's P/E ratio is -13.30. In terms of profitability, VREX's ROE is +0.05%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, VREX is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check OFIX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CARL has a market cap of 380.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CARL trades at $13.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CARL's P/E ratio is -9.78. In terms of profitability, VREX's ROE is +0.05%, compared to CARL's ROE of -0.38%. Regarding short-term risk, VREX is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CARL's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PACB trades at $1.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PACB's P/E ratio is -2.80. In terms of profitability, VREX's ROE is +0.05%, compared to PACB's ROE of -49.62%. Regarding short-term risk, VREX is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PACB's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PMI has a market cap of 354.8M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PMI trades at $3.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PMI's P/E ratio is -2.88. In terms of profitability, VREX's ROE is +0.05%, compared to PMI's ROE of +4.99%. Regarding short-term risk, VREX is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PMI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CATX has a market cap of 352.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CATX trades at $3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CATX's P/E ratio is -2.19. In terms of profitability, VREX's ROE is +0.05%, compared to CATX's ROE of -0.42%. Regarding short-term risk, VREX is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CATX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ELMD has a market cap of 351.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ELMD trades at $42.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ELMD's P/E ratio is 36.24. In terms of profitability, VREX's ROE is +0.05%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, VREX is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ELMD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, TLSI has a market cap of 346.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while TLSI trades at $5.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas TLSI's P/E ratio is -3.35. In terms of profitability, VREX's ROE is +0.05%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, VREX is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TLSI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while CV trades at $6.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas CV's P/E ratio is -2.72. In terms of profitability, VREX's ROE is +0.05%, compared to CV's ROE of +1.27%. Regarding short-term risk, VREX is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for VREX.Check CV's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SENS has a market cap of 323.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SENS trades at $7.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SENS's P/E ratio is -3.86. In terms of profitability, VREX's ROE is +0.05%, compared to SENS's ROE of -1.66%. Regarding short-term risk, VREX is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check SENS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while SMLR trades at $20.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas SMLR's P/E ratio is 3.92. In terms of profitability, VREX's ROE is +0.05%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, VREX is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for VREX.Check SMLR's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while TMCI trades at $4.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas TMCI's P/E ratio is -4.80. In terms of profitability, VREX's ROE is +0.05%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, VREX is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check TMCI's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, RXST has a market cap of 290.2M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while RXST trades at $7.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas RXST's P/E ratio is -7.54. In terms of profitability, VREX's ROE is +0.05%, compared to RXST's ROE of -0.17%. Regarding short-term risk, VREX is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for VREX.Check RXST's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ANIK has a market cap of 283.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ANIK trades at $21.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ANIK's P/E ratio is 43.20. In terms of profitability, VREX's ROE is +0.05%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, VREX is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for VREX.Check ANIK's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while MGRM trades at $6.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas MGRM's P/E ratio is -12.00. In terms of profitability, VREX's ROE is +0.05%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, VREX is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for VREX.Check MGRM's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, PROF has a market cap of 242.4M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while PROF trades at $6.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas PROF's P/E ratio is -5.38. In terms of profitability, VREX's ROE is +0.05%, compared to PROF's ROE of -0.56%. Regarding short-term risk, VREX is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for VREX.Check PROF's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while NVRO trades at $5.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VREX's ROE is +0.05%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VREX is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for VREX.Check NVRO's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while STIM trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas STIM's P/E ratio is -5.61. In terms of profitability, VREX's ROE is +0.05%, compared to STIM's ROE of -1.51%. Regarding short-term risk, VREX is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check STIM's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, RCEL has a market cap of 199M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while RCEL trades at $8.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas RCEL's P/E ratio is -5.10. In terms of profitability, VREX's ROE is +0.05%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, VREX is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check RCEL's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while BSGM trades at $6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas BSGM's P/E ratio is -5.81. In terms of profitability, VREX's ROE is +0.05%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, VREX is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for VREX.Check BSGM's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, LUCD has a market cap of 184.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while LUCD trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas LUCD's P/E ratio is -2.61. In terms of profitability, VREX's ROE is +0.05%, compared to LUCD's ROE of -0.02%. Regarding short-term risk, VREX is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for VREX.Check LUCD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while MDGS trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas MDGS's P/E ratio is -0.27. In terms of profitability, VREX's ROE is +0.05%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, VREX is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for VREX.Check MDGS's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while FOCL trades at $4.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas FOCL's P/E ratio is -5.80. In terms of profitability, VREX's ROE is +0.05%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, VREX is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for VREX.Check FOCL's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while QIPT trades at $3.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas QIPT's P/E ratio is -15.87. In terms of profitability, VREX's ROE is +0.05%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, VREX is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for VREX.Check QIPT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while INGN trades at $5.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas INGN's P/E ratio is -6.38. In terms of profitability, VREX's ROE is +0.05%, compared to INGN's ROE of -0.13%. Regarding short-term risk, VREX is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for VREX.Check INGN's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, QTRX has a market cap of 134.7M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while QTRX trades at $2.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas QTRX's P/E ratio is -1.79. In terms of profitability, VREX's ROE is +0.05%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, VREX is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for VREX.Check QTRX's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, OWLT has a market cap of 114.5M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while OWLT trades at $6.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas OWLT's P/E ratio is -45.21. In terms of profitability, VREX's ROE is +0.05%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, VREX is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check OWLT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while ICAD trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas ICAD's P/E ratio is -20.37. In terms of profitability, VREX's ROE is +0.05%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, VREX is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for VREX.Check ICAD's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, HSDT has a market cap of 105.1M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while HSDT trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas HSDT's P/E ratio is -0.02. In terms of profitability, VREX's ROE is +0.05%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, VREX is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for VREX.Check HSDT's competition here

Varex Imaging Corporation (NASDAQ: VREX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VREX stands at 778.9M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, VREX is priced at $18.50 on the NASDAQ, while HJLI trades at $10.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VREX currently has a P/E ratio of 19.47, whereas HJLI's P/E ratio is N/A. In terms of profitability, VREX's ROE is +0.05%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, VREX is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for VREX.Check HJLI's competition here